drugset / Trial / NCT01584518
B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading
RandomizedParallel-groupTriple-blindTreatment
Summary
The long-range goal of this proposal is to decrease morbidity and mortality related to pulmonary edema and congestive heart failure (CHF) in post-operative patients. The short-range goal is to determine a mechanistic endpoint when therapy for impending heart failure can be initiated and terminated based on B-type natriuretic peptide (BNP) levels. The investigators propose to utilize changing levels of BNP as a surrogate marker for CHF.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Furosemide | Other / unclassified | — | — |
Indications
No indication recorded.